Solanezumab does not slow cognitive decline in preclinical Alzheimer disease
by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&
Updated on: April 02,2024
19
Solanezumab does not slow cognitive decline in preclinical Alzheimer disease
by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&
Updated on:April 02,2024
19